首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Susceptibility of Multiresistant Gram-Negative Bacteria to Fosfomycin and Performance of Different Susceptibility Testing Methods
【2h】

Susceptibility of Multiresistant Gram-Negative Bacteria to Fosfomycin and Performance of Different Susceptibility Testing Methods

机译:多重耐药革兰氏阴性菌对磷霉素的敏感性及不同敏感性试验方法的性能

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Fosfomycin may be a treatment option for multiresistant Gram-negative bacteria. This study compared susceptibility methods using 94 multiresistant clinical isolates. With agar dilution (AD), susceptibilities were 81%, 7%, 96%, and 100% (CLSI) and 0%, 0%, 96%, and 30% (EUCAST), respectively, for Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Enterobacter spp. Categorical agreement between Etest and AD for Enterobacteriaceae and A. baumannii was ≥80%. Disk diffusion was adequate only for Enterobacter. CLSI criteria for urine may be adequate for systemic infections.
机译:磷霉素可能是多重耐药革兰氏阴性菌的治疗选择。这项研究比较了使用94种多耐药临床分离株的药敏方法。使用琼脂稀释液(AD),鲍曼不动杆菌,铜绿假单胞菌的敏感性分别为81%,7%,96%和100%(CLSI)和0%,0%,96%和30%(EUCAST),肺炎克雷伯菌和肠杆菌属。 Etest和AD对肠杆菌科和鲍曼不动杆菌的分类一致性≥80%。盘扩散仅对肠杆菌是足够的。尿液的CLSI标准可能足以应对全身感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号